DOI: https://doi.org/10.55522/jmpas.V14I3.6913
VOLUME 14 – ISSUE 3, MAY - JUNE 2025
Sanjay Dhiman, Anjali Dixit*, Rambabu Sharma, Ankita Goyal
Department of of Pharmaceuties, Himalyan Institute of Pharmacy, Sirmour, Himachal Pradesh, India
Refer this article
Sanjay Dhiman, Anjali Dixit, Rambabu Sharma, Ankita Goyal, 2025. Pharmacovigilance: strenthening drug safety through monitoring and reporting. Journal of medical pharmaceutical and allied sciences, V 14 - I 3, Pages - 49 – 54. Doi: https://doi.org/10.55522/jmpas.V14I3.6913
ABSTRACT
Pharmacovigilance is essential to clinical research and is a key element in guaranteeing the safety of medications. It is described as the study and practice of recognizing, evaluating, understanding, and averting adverse medication reactions or other problems.The goal of pharmacovigilance, a continuous monitoring procedure, is to identify and address safety concerns with medications that are currently on the market. The review's primary focus is on the purpose, necessity, and role of medicine regulation. Lately drug surveillance has been limited, mostly to identify previously undiscovered or unfavorable drug events that are not well understood. A lot of drug safety facilities are currently striving to monitor medication safety in this universal arena; yet, at the turn of the decade, medication surveillance faces significant obstacles in the area of improved drug administration and control. Pill security, global monitoring centers and their role, reach, necessity, cooperation, and collaboration will all be covered in this study.
Keywords:
Pharmacovigilance, Medication safety, Drug surveillance, Clinical research, Global monitoring.